Lessons learned from the development of imatinib

Nicholas B. Lydon; Brian J. Druker

doi:10.1016/j.leukres.2003.10.002

Lessons learned from the development of imatinib

Nicholas B. Lydon, Brian J. Druker

Knight Cancer Institute

Research output: Contribution to journal › Article › peer-review

51 Scopus citations

Original language	English (US)
Pages (from-to)	S29-S38
Journal	Leukemia Research
Volume	28
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1016/j.leukres.2003.10.002
State	Published - May 2004

Keywords

Bcr-Abl
CML
Drug design
Imatinib
STI 571
Tyrosine kinase

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.leukres.2003.10.002

Cite this

@article{1b4dc1d0d6654b92a9fb7c4117a36c73,

title = "Lessons learned from the development of imatinib",

keywords = "Bcr-Abl, CML, Drug design, Imatinib, STI 571, Tyrosine kinase",

author = "Lydon, {Nicholas B.} and Druker, {Brian J.}",

year = "2004",

month = may,

doi = "10.1016/j.leukres.2003.10.002",

language = "English (US)",

volume = "28",

pages = "S29--S38",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Limited",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Lessons learned from the development of imatinib

AU - Lydon, Nicholas B.

AU - Druker, Brian J.

PY - 2004/5

Y1 - 2004/5

KW - Bcr-Abl

KW - CML

KW - Drug design

KW - Imatinib

KW - STI 571

KW - Tyrosine kinase

UR - http://www.scopus.com/inward/record.url?scp=1342321786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1342321786&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2003.10.002

DO - 10.1016/j.leukres.2003.10.002

M3 - Article

C2 - 15036939

AN - SCOPUS:1342321786

SN - 0145-2126

VL - 28

SP - S29-S38

JO - Leukemia Research

JF - Leukemia Research

IS - SUPPL. 1

ER -

Lessons learned from the development of imatinib

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this